Clinical evaluation of a new method for liver segmentation based on 3D visualization technology
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- ChiCTR2400088777
- Lead Sponsor
- Air Force Medical Center of PLA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
? Patients with CNLC-Ia, Ib, IIa/BCLC-A stage hepatocellular carcinoma; Or other stages that are deemed suitable for one-stage resection after multidisciplinary evaluation; ? Liver function classification Child Pugh A; ? ECOG-PS 0 or 1 point; ? ICG-R15<30%; ? 18-75 years old; ? Sign the informed consent form and agree to participate in the clinical study.
Exclusion Criteria
? Individuals at risk of severe portal hypertension or esophageal and gastric variceal bleeding Those who are unwilling to undergo laparoscopic surgery or participate in clinical trials Patients with concurrent malignant tumor diseases.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compliance rate of portal vein territory-based anatomic hepatectomy;
- Secondary Outcome Measures
Name Time Method Postoperative liver dysfunction;operative time;blood loss during operation;complication;Progression free survival (PFS) One year postoperative ;Recurrence free survival (RFS) One year postoperative ;